๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

High dose methotrexate population pharmacokinetics and Bayesian estimation in patients with lymphoid malignancy

โœ Scribed by Ye Min; Fu Qiang; Li Peng; Zhu Zhu

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
244 KB
Volume
30
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

High-dose methotrexate with citrovorum f
High-dose methotrexate with citrovorum factor and vincristine in the treatment of malignant mesothelioma
โœ Nikolay V. Dimitrov; James Egner; Ernie Balcueva; Leif G. Suhrland ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 272 KB ๐Ÿ‘ 3 views

The incidence of malignant mesothelioma has increased greatly in the last 40 years. Current and recent past exposure to asbestos is expected to substantially increase this incidence. We report nine cases of malignant mesothelioma which temporarily responded to treatment with high-dose methotrexate-c

High-dose methotrexate-induced nephrotox
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma : Incidence, treatment, and outcome
โœ Brigitte C. Widemann; Frank M. Balis; Beate Kempf-Bielack; Stefan Bielack; Charl ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 114 KB ๐Ÿ‘ 1 views

The authors thank Dr. James Balow at the National Institute of Diabetes, and Digestive, and Kidney Disorders for helpful suggestions during the preparation of this article. This article is dedicated to the memory of Dr. Charles Pratt, who devoted his extraordinary career to the treatment of children

High dose methotrexate followed by citro
High dose methotrexate followed by citrovorum factor reversal in patients with advanced cancer
โœ Edward P. Ambinder; Marjorie Perloff; Takao Ohnuma; Hugh F. Biller; James F. Hol ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 506 KB

High dose methotrexate followed by citrovorum factor reversal has been utilized in twenty-six patients with advanced cancer. Four of 10 patients with head and neck cancer had an objective response. One of 7 patients with metastatic osteosarcoma to the lungs had stabilization with twenty treatments o